Topical Finasteride Speed: Does Skipping the Bloodstream Change Onset?

Both oral and topical finasteride suppress scalp DHT. The hair follicle cycle responds to that suppression on the same biological clock regardless of delivery route.

Topical finasteride is delivered directly to the scalp rather than through systemic circulation. A reasonable intuition: if you target the site of action directly, maybe the onset is faster. The evidence on this is more nuanced.

How topical finasteride reaches the follicle

Applied to the scalp, finasteride penetrates the stratum corneum and distributes into the dermis where the hair follicle's dermal papilla cells reside. This takes hours per application. With repeated daily applications, drug accumulates in scalp tissue. The local DHT suppression builds to a steady-state level over days to weeks of consistent application — a timeline similar to oral reaching steady-state via systemic distribution.

Does delivery route change the DHT suppression onset?

Not meaningfully in terms of the follicle-level clock. Optimised topical formulations achieve scalp DHT reductions in the same approximate range as oral (60–70% in studies using scalp biopsy samples). Both reach this steady-state level within days to weeks. The onset of local DHT suppression is comparable.

The bottleneck is always the follicle cycle

Whatever the delivery route, the rate-limiting step for clinical results is the hair follicle's growth cycle. The follicle does not respond to DHT suppression on the timescale of days — it operates on months. The dread shed, stabilisation, and early regrowth follow the same approximate timeline regardless of whether the DHT suppression was achieved orally or topically.

The choice between oral and topical turns on the systemic exposure trade-off, not on which one works faster. Both reach the follicle at clinically relevant DHT suppression levels within a similar timeframe.